These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20099277)

  • 1. Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells.
    Plissonnier ML; Fauconnet S; Bittard H; Lascombe I
    Int J Cancer; 2010 Oct; 127(8):1769-84. PubMed ID: 20099277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
    Plissonnier ML; Fauconnet S; Bittard H; Lascombe I
    PLoS One; 2011; 6(12):e28354. PubMed ID: 22174792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.
    Schultze K; Böck B; Eckert A; Oevermann L; Ramacher D; Wiestler O; Roth W
    Apoptosis; 2006 Sep; 11(9):1503-12. PubMed ID: 16820965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
    Zhang T; Wang X; He D; Jin X; Guo P
    Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.
    Zou W; Liu X; Yue P; Khuri FR; Sun SY
    Cancer Biol Ther; 2007 Jan; 6(1):99-106. PubMed ID: 17172826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anti-diabetic drug troglitazone sensitizes colon cancer cells to TRAIL-induced apoptosis by down-regulating FLIP].
    Roth W; Grund K; Wiestler OD; Schirmacher P
    Verh Dtsch Ges Pathol; 2007; 91():294-301. PubMed ID: 18314627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD.
    Grund K; Ahmadi R; Jung F; Funke V; Gdynia G; Benner A; Sykora J; Walczak H; Joos S; Felsberg J; Reifenberger G; Wiestler OD; Herold-Mende C; Roth W
    Cancer Biol Ther; 2008 Dec; 7(12):1982-90. PubMed ID: 19158480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
    Péchery A; Fauconnet S; Bittard H; Lascombe I
    Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.
    Bräutigam K; Biernath-Wüpping J; Bauerschlag DO; von Kaisenberg CS; Jonat W; Maass N; Arnold N; Meinhold-Heerlein I
    J Cancer Res Clin Oncol; 2011 May; 137(5):875-86. PubMed ID: 20878528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
    Lu M; Kwan T; Yu C; Chen F; Freedman B; Schafer JM; Lee EJ; Jameson JL; Jordan VC; Cryns VL
    J Biol Chem; 2005 Feb; 280(8):6742-51. PubMed ID: 15569667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.
    Szliszka E; Mazur B; Zydowicz G; Czuba ZP; Król W
    Folia Histochem Cytobiol; 2009; 47(4):579-85. PubMed ID: 20430723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility to TRAIL of normal versus malignant human urothelial cells.
    Steele LP; Georgopoulos NT; Southgate J; Selby PJ; Trejdosiewicz LK
    Cell Death Differ; 2006 Sep; 13(9):1564-76. PubMed ID: 16410800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux.
    Nazim UM; Moon JH; Lee YJ; Seol JW; Park SY
    Oncotarget; 2017 Apr; 8(16):26819-26831. PubMed ID: 28460464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
    Chaffer CL; Thomas DM; Thompson EW; Williams ED
    BMC Cancer; 2006 Mar; 6():53. PubMed ID: 16519808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.